Please enable JavaScript to continue using this application.

Compare $CABA vs $CATX | Chartloom

Compare

$CABA vs $CATX

Cabaletta Bio Inc · Perspective Therapeutics Inc

CABA

Cabaletta Bio Inc

CATX

Perspective Therapeutics Inc

Compare $CABA vs $CATX

Comparing Cabaletta Bio Inc and Perspective Therapeutics Inc

CABACabaletta Bio Inc

CATXPerspective Therapeutics Inc

CABACabaletta Bio Inc

Market cap

$315M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-12.7%

52W performance

-19.9%

FCF yield

-49.0%

CATXPerspective Therapeutics Inc

Market cap

$303M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-66.9%

YTD performance

-4.7%

52W performance

-31.1%

FCF yield

-40.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CABA

CATX

Detailed metrics comparison

CABA

Cabaletta Bio Inc

CATX

Perspective Therapeutics Inc

Market Cap

CABA$315M

CATX$303M

Enterprise Value

CABA$110M

CATX$256M

Price

CABA$1.93

CATX$2.66

P/E Ratio

CABAN/A

CATXN/A

P/S Ratio

CABA0.00x

CATX741.74x

EV/Sales

CABA0.00x

CATX627.10x

EV/EBITDA

CABA0.00x

CATX0.00x

P/B Ratio

CABA1.61x

CATX0.97x

P/FCF Ratio

CABAN/A

CATXN/A

EV/FCF

CABA-0.71x

CATX-2.11x

PEG Ratio

CABAN/A

CATXN/A

Forward P/E (NTM)

CABAN/A

CATXN/A

Forward P/S (NTM)

CABAN/A

CATXN/A

Revenue (TTM)

CABA$0

CATX$409K

Revenue Growth (YoY)

CABAN/A

CATX-66.9%

Forward Rev Growth

CABA452.2%

CATX32.5%

Gross Margin (TTM)

CABA0.0%

CATX23.0%

Operating Margin (TTM)

CABA0.0%

CATX0.0%

EBITDA Margin (TTM)

CABA0.0%

CATX-29628.1%

Net Margin (TTM)

CABA0.0%

CATX-28468.0%

FCF Margin (TTM)

CABAN/A

CATX-29657.2%

Net Income (TTM)

CABA$-181M

CATX$-116M

FCF (TTM)

CABA$-154M

CATX$-121M

EPS (TTM)

CABA-$1.20

CATX-$0.97

ROE (TTM)

CABA-12827.0%

CATX-4156.0%

ROA (TTM)

CABA-9547.0%

CATX-3413.0%

ROIC (TTM)

CABA-11070.0%

CATX-4132.0%

Cash

CABA$225M

CATX$48M

Debt

CABA$20M

CATX$2M

Net Cash/Debt

CABA$205M

CATX$47M

Current Ratio (TTM)

CABA5.79x

CATX6.61x

Quick Ratio (TTM)

CABA5.64x

CATX6.49x

Debt/Equity (TTM)

CABA0.09x

CATX0.00x

Debt/Assets (TTM)

CABA0.0%

CATX0.0%

Interest Coverage (TTM)

CABAN/A

CATXN/A

Net Debt/EBITDA (TTM)

CABA0.00x

CATX0.00x

Beta

CABA3.54

CATX1.87

52W Performance

CABA-19.9%

CATX-31.1%

YTD Performance

CABA-12.7%

CATX-4.7%

% from 52W High

CABA-54.4%

CATX-56.8%

% from 52W Low

CABA5.5%

CATX35.7%

Asset Turnover (TTM)

CABA0.00x

CATX0.00x

FCF Yield (TTM)

CABA-49.0%

CATX-40.0%

Earnings Yield (TTM)

CABA-57.6%

CATX-38.4%

Dividend Yield (TTM)

CABAN/A

CATXN/A

Rule of 40

CABA0.0

CATX-29,724.1

EV/GP/RG

CABAN/A

CATX22.31

Ticker research

View CABA research View CATX research

Metric	CABA Cabaletta Bio Inc	CATX Perspective Therapeutics Inc
Market & Valuation
Market Cap	$315M	$303M
Enterprise Value	$110M	$256M
Price	$1.93	$2.66
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	741.74x
EV/Sales	0.00x	627.10x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.61x	0.97x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.71x	-2.11x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$409K
Revenue Growth (YoY)	N/A	-66.9%
Forward Rev Growth	452.2%	32.5%
Profitability
Gross Margin (TTM)	0.0%	23.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-29628.1%
Net Margin (TTM)	0.0%	-28468.0%
FCF Margin (TTM)	N/A	-29657.2%
Net Income (TTM)	$-181M	$-116M
FCF (TTM)	$-154M	$-121M
EPS (TTM)	-$1.20	-$0.97
ROE (TTM)	-12827.0%	-4156.0%
ROA (TTM)	-9547.0%	-3413.0%
ROIC (TTM)	-11070.0%	-4132.0%
Financial Health
Cash	$225M	$48M
Debt	$20M	$2M
Net Cash/Debt	$205M	$47M
Current Ratio (TTM)	5.79x	6.61x
Quick Ratio (TTM)	5.64x	6.49x
Debt/Equity (TTM)	0.09x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.54	1.87
52W Performance	-19.9%	-31.1%
YTD Performance	-12.7%	-4.7%
% from 52W High	-54.4%	-56.8%
% from 52W Low	5.5%	35.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-49.0%	-40.0%
Earnings Yield (TTM)	-57.6%	-38.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-29,724.1
EV/GP/RG	N/A	22.31
Ticker research	View CABA research	View CATX research

Valuation

P/S Ratio

CABA

0.00x

CATX

741.74x

EV/FCF

CATX

-2.11x

CABA

-0.71x

Growth & revenue

Revenue Growth TTM

CATX

-66.9%

Forward Revenue Growth

CABA

452.2%

CATX

32.5%

Profitability & performance

Gross Margin

CATX

23.0%

CABA

0.0%

ROE

CATX

-4156.0%

CABA

-12827.0%

FCF Yield %

CATX

-40.0%

CABA

-49.0%

52-Week Performance

CABA

-19.9%

CATX

-31.1%

Detailed metrics comparison

CABA

Cabaletta Bio Inc

CATX

Perspective Therapeutics Inc

Market Cap

CABA$315M

CATX$303M

Enterprise Value

CABA$110M

CATX$256M

Price

CABA$1.93

CATX$2.66

P/E Ratio

CABAN/A

CATXN/A

P/S Ratio

CABA0.00x

CATX741.74x

EV/Sales

CABA0.00x

CATX627.10x

EV/EBITDA

CABA0.00x

CATX0.00x

P/B Ratio

CABA1.61x

CATX0.97x

P/FCF Ratio

CABAN/A

CATXN/A

EV/FCF

CABA-0.71x

CATX-2.11x

PEG Ratio

CABAN/A

CATXN/A

Forward P/E (NTM)

CABAN/A

CATXN/A

Forward P/S (NTM)

CABAN/A

CATXN/A

Revenue (TTM)

CABA$0

CATX$409K

Revenue Growth (YoY)

CABAN/A

CATX-66.9%

Forward Rev Growth

CABA452.2%

CATX32.5%

Gross Margin (TTM)

CABA0.0%

CATX23.0%

Operating Margin (TTM)

CABA0.0%

CATX0.0%

EBITDA Margin (TTM)

CABA0.0%

CATX-29628.1%

Net Margin (TTM)

CABA0.0%

CATX-28468.0%

FCF Margin (TTM)

CABAN/A

CATX-29657.2%

Net Income (TTM)

CABA$-181M

CATX$-116M

FCF (TTM)

CABA$-154M

CATX$-121M

EPS (TTM)

CABA-$1.20

CATX-$0.97

ROE (TTM)

CABA-12827.0%

CATX-4156.0%

ROA (TTM)

CABA-9547.0%

CATX-3413.0%

ROIC (TTM)

CABA-11070.0%

CATX-4132.0%

Cash

CABA$225M

CATX$48M

Debt

CABA$20M

CATX$2M

Net Cash/Debt

CABA$205M

CATX$47M

Current Ratio (TTM)

CABA5.79x

CATX6.61x

Quick Ratio (TTM)

CABA5.64x

CATX6.49x

Debt/Equity (TTM)

CABA0.09x

CATX0.00x

Debt/Assets (TTM)

CABA0.0%

CATX0.0%

Interest Coverage (TTM)

CABAN/A

CATXN/A

Net Debt/EBITDA (TTM)

CABA0.00x

CATX0.00x

Beta

CABA3.54

CATX1.87

52W Performance

CABA-19.9%

CATX-31.1%

YTD Performance

CABA-12.7%

CATX-4.7%

% from 52W High

CABA-54.4%

CATX-56.8%

% from 52W Low

CABA5.5%

CATX35.7%

Asset Turnover (TTM)

CABA0.00x

CATX0.00x

FCF Yield (TTM)

CABA-49.0%

CATX-40.0%

Earnings Yield (TTM)

CABA-57.6%

CATX-38.4%

Dividend Yield (TTM)

CABAN/A

CATXN/A

Rule of 40

CABA0.0

CATX-29,724.1

EV/GP/RG

CABAN/A

CATX22.31

Ticker research

View CABA research View CATX research

Metric	CABA Cabaletta Bio Inc	CATX Perspective Therapeutics Inc
Market & Valuation
Market Cap	$315M	$303M
Enterprise Value	$110M	$256M
Price	$1.93	$2.66
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	741.74x
EV/Sales	0.00x	627.10x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.61x	0.97x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.71x	-2.11x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$409K
Revenue Growth (YoY)	N/A	-66.9%
Forward Rev Growth	452.2%	32.5%
Profitability
Gross Margin (TTM)	0.0%	23.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-29628.1%
Net Margin (TTM)	0.0%	-28468.0%
FCF Margin (TTM)	N/A	-29657.2%
Net Income (TTM)	$-181M	$-116M
FCF (TTM)	$-154M	$-121M
EPS (TTM)	-$1.20	-$0.97
ROE (TTM)	-12827.0%	-4156.0%
ROA (TTM)	-9547.0%	-3413.0%
ROIC (TTM)	-11070.0%	-4132.0%
Financial Health
Cash	$225M	$48M
Debt	$20M	$2M
Net Cash/Debt	$205M	$47M
Current Ratio (TTM)	5.79x	6.61x
Quick Ratio (TTM)	5.64x	6.49x
Debt/Equity (TTM)	0.09x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.54	1.87
52W Performance	-19.9%	-31.1%
YTD Performance	-12.7%	-4.7%
% from 52W High	-54.4%	-56.8%
% from 52W Low	5.5%	35.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-49.0%	-40.0%
Earnings Yield (TTM)	-57.6%	-38.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-29,724.1
EV/GP/RG	N/A	22.31
Ticker research	View CABA research	View CATX research